Hamilton Lab
The Hamilton Lab is focused on better understanding the etiology and pathophysiology of cardiomyopathies, with the goal of improving diagnosis and treatment.
Personal Statement
I have extensive research experience in the etiology, diagnosis and management of congestive heart failure and cardiomyopathy. One of my research areas focuses on the interface of psychiatry and heart failure, including depression, sleep disorders and quality of life. I also have research interests in thyroid and other hormonal abnormalities and therapies in heart failure patients, as well as echocardiographic assessment of heart failure severity and hemodynamic treatment, including percutaneous mitral valve interventions.
Michele Hamilton
Breakthrough Research
- Comparing the effectiveness of behavioral therapy versus antidepressant medication management in heart failure patients
- Understanding the mechanisms involved in impaired functional capacity limitation in heart failure patients
- Studying the effects of endocrine and metabolic abnormalities, particularly abnormal thyroid hormone function and obesity, on cardiac function
- Investigating the role of noninvasive diagnostic tools in assessing hemodynamics
Publications
Learn more about the recent research publications from the Hamilton Lab.
Job Opportunities
We are actively recruiting students and postdocs to be our colleagues and expand lab knowledge and expertise to make important breakthroughs.
Collaborations
The Hamilton Lab collaborates with a wide range of investigators within Cedars-Sinai and institutions around the world.